Fig. 6From: Development and validation of a novel competing risk model for predicting survival of esophagogastric junction adenocarcinoma: a SEER population-based study and external validationDecision curve analysis for the Competing Risk Nomogram and the 8th TNM Stage in prediction of prognosis of patients at 1, 3, 5, 7, 10-year pointBack to article page